Errata by unknown
Page 928, in the DISCUSSION section, 2nd sentence, we should read:
Therefore, OMACOR is a cost-effective prophylactic treatment for patients after an MI, both in terms of cost per
LYG and QALY gained, namely £12,011 and £15,189 over a 4-year period; or of £2,812 and £3,723 over a lifetime.
Reference
1 Quilici S, Martin M, McGuire A, Zoellner Y. A cost-effectiveness analysis of n-3 PUFA (Omacor ) treatment in post-MI patients’. Int J Clin
Pract 2006; 60: 922–32.
Original paper ‘Lercanidipine is an effective and well tolerated antihypertensive drug regardless the
cardiovascular risk proﬁle: the LAURA study’. Int J Clin Pract 2006; 60: 1364–70.
Since publication, an error has been spotted in table 2 which meant that the percentage symbol was
excluded. The corrected table is detailed below.
Reference
1 Barrios V, Escobar C, Navarro A ´, Barrios L, Navarro-Cid J, Caldero ´n A. Lercanidipine is an effective and well tolerated antihypertensive drug
regardless the cardiovascular risk proﬁle: the LAURA study’. Int J Clin Pract 2006; 60: 1364–70.
Table 2 Characteristics of the study population at baseline (n ¼ 3175)
Variables
Biodemographic data
Sex (male/female) (%) M: 49 F: 51
Age (years), mean ± SD 63±10
BMI (kg/m
2), mean ± SD M: 28.2±3.8 F: 28.3±4.2
Waist circumference (cm), mean ± SD M: 101.3 ± 12.2 F: 96.8±14.1
Cardiovascular risk factors (%)
Grade I hypertension 43
Grade II hypertension 57
Hypercholesterolemia 32
Current smoking 30
Family history cardiovascular disease 16
Diabetes mellitus 15
Target organ damage (%)
Left ventricular hypertrophy 18
Atherosclerotic plaques 7
Mild renal impairment/microalbuminuria 5
Associated clinical conditions (%)
Ischaemic heart disease 10
Peripheral arterial disease 6
Congestive heart failure 4
Renal failure 4
Cerebrovascular disease 3
Advanced retinopathy 1
Cardiovascular risk (%)
Low risk 7.5
Medium risk 44
High 22.7
Very high 25.8
Clinical data (mean ± SD)
SBP (mmHg) 159.5 ± 11.7
DBP (mmHg) 95.2 ± 7.4
Heart rate (bpm) 68.4 ± 4.2
M, male; F, female; BMI, body mass index; SBP, systolic blood pressure; DPB, diastolic blood pressure.
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